Binding of Thrombin-Activated Platelets to a Fibrin Scaffold through αIIbβ3 Evokes Phosphatidylserine Exposure on Their Cell Surface
TLDR
It is suggested that outside-in signals in platelets generated by their binding to the rigid fibrin network are essential for PS exposure after thrombin treatment.Abstract:
Recently, by employing intra-vital confocal microscopy, we demonstrated that platelets expose phosphatidylserine (PS) and fibrin accumulate only in the center of the thrombus but not in its periphery. To address the question how exposure of platelet anionic phospholipids is regulated within the thrombus, an in-vitro experiment using diluted platelet-rich plasma was employed, in which the fibrin network was formed in the presence of platelets, and PS exposure on the platelet surface was analyzed using Confocal Laser Scanning Microscopy. Almost all platelets exposed PS after treatment with tissue factor, thrombin or ionomycin. Argatroban abrogated fibrin network formation in all samples, however, platelet PS exposure was inhibited only in tissue factor- and thrombin-treated samples but not in ionomycin-treated samples. FK633, an α(IIb)β₃ antagonist, and cytochalasin B impaired platelet binding to the fibrin scaffold and significantly reduced PS exposure evoked by thrombin. Gly-Pro-Arg-Pro amide abrogated not only fibrin network formation, but also PS exposure on platelets without suppressing platelet binding to fibrin/fibrinogen. These results suggest that outside-in signals in platelets generated by their binding to the rigid fibrin network are essential for PS exposure after thrombin treatment.read more
Citations
More filters
Journal ArticleDOI
Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.
Valerie Tutwiler,Valerie Tutwiler,Rustem I. Litvinov,Andrey Lozhkin,Alina D. Peshkova,Tatiana Lebedeva,Fazoil I. Ataullakhanov,Kara L. Spiller,Douglas B. Cines,John W. Weisel +9 more
TL;DR: A novel automated optical analyzer was used to continuously track in vitro changes in the size of contracting clots in whole blood and in variously reconstituted samples to investigate the coordinated mechanistic impact of platelets, including nonmuscle myosin II, red blood cells, fibrin(ogen), factor XIIIa (FXIIIa), and thrombin on the kinetics and mechanics of the contraction process.
Journal ArticleDOI
Regulation of plasminogen activation on cell surfaces and fibrin
TL;DR: This suggests that the plasma procarboxypeptidase B, thrombin‐activatable fibrinolysis inhibitor (TAFI), which is activated byThrombin bound to TM on VECs, is a critical aspect of the regulation of plg activation on V ECs and subsequent fibrinoslysis.
Journal ArticleDOI
Application of microfluidic devices in studies of thrombosis and hemostasis.
TL;DR: A review of the current state of the art for microfluidic devices and their applications in the field of thrombosis and hemostasis is summarized.
Journal ArticleDOI
Dual antiplatelet therapy with clopidogrel and aspirin increases mortality in 4T1 metastatic breast cancer-bearing mice by inducing vascular mimicry in primary tumour.
Marta Smeda,Anna Kieronska,Bartosz Proniewski,Agnieszka Jasztal,Anna Selmi,Krystyna Wandzel,Agnieszka Zakrzewska,Tomasz Wojcik,Kamil Przyborowski,Katarzyna Derszniak,Marta Stojak,Dawid Kaczor,Elzbieta Buczek,Cezary Watala,Joanna Wietrzyk,Stefan Chlopicki,Stefan Chlopicki +16 more
TL;DR: Dual anti-platelet therapy based on aspirin and clopidogrel (ASA+Cl), a routine regiment in cardiovascular patients, when given to cancer-bearing mice injected orthotopically with 4T1 breast cancer cells, promoted progression of the disease and reduced mice survival in association with induction of vascular mimicry (VM) in primary tumour.
Journal ArticleDOI
Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site-dependent plasminogen accumulation in microthrombi.
TL;DR: Glu-plg appeared to accumulate in the center of microthrombi in the early phase of microstrombus formation, and plasmin activity and lysine binding sites were required for this accumulation.
References
More filters
Journal ArticleDOI
Aggregation of blood platelets by adenosine diphosphate and its reversal.
Journal ArticleDOI
A cell-based model of hemostasis
TL;DR: This model emphasizes the importance of specific cellular receptors for the coagulation proteins and explains some aspects of hemostasis that a protein-centric model does not.
Journal ArticleDOI
Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells
TL;DR: This work has shown that the outer leaflet of eukaryotic plasma membranes is formed predominantly with the cholinephospholipids (sphingomyelin and phosphatidylcholine [PC], whereas the majority of the
Journal ArticleDOI
Preparation of Suspensions of Washed Platelets from Humans
TL;DR: Methods have been developed for the preparation of suspensions of washed platelets from humans and platelets suspended in Eagle's tissue culture medium containing albumin were more responsive to ADP than platelets in Tyrode's‐albumin solution.
Journal ArticleDOI
Calcium-dependent phospholipid scrambling by TMEM16F
TL;DR: It is shown that TMEM16F (transmembrane protein 16F) is an essential component for the Ca2+-dependent exposure of PtdSer on the cell surface, which results from a defect in phospholipid scrambling activity and is found to carry a mutation at a splice-acceptor site of the gene encoding TMEM 16F, causing the premature termination of the protein.
Related Papers (5)
Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
Nadine J.A. Mattheij,Frauke Swieringa,Tom G. Mastenbroek,Michelle A. Berny-Lang,Frauke May,Constance C.F.M.J. Baaten,Paola E. J. van der Meijden,Yvonne M. C. Henskens,Erik A M Beckers,Dennis Suylen,Marc W. Nolte,Tilman M. Hackeng,Owen J. T. McCarty,Johan W. M. Heemskerk,Judith M.E.M. Cosemans +14 more